Olgu Sunumu

Evaluation of the effects of neoadjuvant chemotherapy on probably benign breast lesions with MRI: Report of two cases

Cilt: 61 Sayı: 2 13 Haziran 2022
  • Özge Aslan *
  • Ayşenur Oktay
  • Levent Yeniay
Ege Tıp Dergisi Kapak
Ege Tıp Dergisi
PDF İndir
EN TR

Evaluation of the effects of neoadjuvant chemotherapy on probably benign breast lesions with MRI: Report of two cases

Abstract

In cases with breast cancer, probably benign lesions can also be seen in the other areas of the breast. It is known that neoadjuvant chemotherapy causes morphological changes in the normal breast tissue and the benign lesions, in addition to effects on malignant mass. In cases with complete response with neoadjuvant chemotherapy, probably benign lesions without tissue diagnosis cause a dilemma in the breast conserving surgery plan, when they shrink or disappear at the end of the treatment. We aimed to demonstrate the effects of neoadjuvant chemotherapy in cases with probably benign breast lesions via dynamic contrast enhanced breast MRI.

Keywords

Kaynakça

  1. Panigrahi B, Harvey SC, Mullen LA, et al. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI. Clin Breast Cancer. 2019 Feb; 19 (1): e152-e159.
  2. Schott AF, Roubidoux MA, Helvie MA, et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat. 2005 Aug; 92 (3): 231-8.
  3. Symmans WF, Peintinger F, Hatzis C, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007 Oct 1; 25 (28): 4414-22.
  4. Ah-See ML, Makris A, Taylor NJ, et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res. 2008 Oct 15; 14 (20): 6580-9.
  5. Carder P. Typing breast cancer following primary chemotherapy. Histopathology. 1999 Dec; 35 (6): 584-5.
  6. Yeh E, Slanetz P, Kopans DB, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol. 2005 Mar; 184 (3): 868-77.
  7. Leddy R, Irshad A, Hewett L, et al. Effects of neoadjuvant chemotherapy on benign breast lesions compared to cancers: Should an additional lesion on magnetic resonance imaging responding similar to cancer after neoadjuvant chemotherapy be viewed with suspicion? J Clin Imaging Sci. 2016 Sep 20; 6: 39.
  8. Gu YL, Pan SM, Ren J, Yang ZX, Jiang GQ. Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis. Clin Breast Cancer. 2017 Jul; 17 (4): 245-55.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Olgu Sunumu

Yazarlar

Özge Aslan *
0000-0001-6935-1472
Türkiye

Ayşenur Oktay
0000-0003-0209-5878
Türkiye

Levent Yeniay
0000-0001-5790-798X
Türkiye

Yayımlanma Tarihi

13 Haziran 2022

Gönderilme Tarihi

7 Mayıs 2021

Kabul Tarihi

20 Kasım 2021

Yayımlandığı Sayı

Yıl 2022 Cilt: 61 Sayı: 2

DOI

https://doi.org/10.19161/etd.1127760

IZ

https://izlik.org/JA79DH26AK

Kaynak Göster

RIS / Bibtex
Vancouver
1.Özge Aslan, Ayşenur Oktay, Levent Yeniay. Evaluation of the effects of neoadjuvant chemotherapy on probably benign breast lesions with MRI: Report of two cases. ETD. 01 Haziran 2022;61(2):298-301. doi:10.19161/etd.1127760

Cited By

Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study

Diagnostic and Interventional Radiology

https://doi.org/10.4274/dir.2023.232393

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.